Detalhe da pesquisa
1.
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
N Engl J Med
; 387(1): 9-20, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35665782
2.
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
N Engl J Med
; 385(25): 2336-2347, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914339
3.
Palbociclib with Fulvestrant or Letrozole in Endocrine-Sensitive Patients with HR-Positive/HER2-Negative Advanced Breast Cancer: A Detailed Safety Analysis of the Randomized PARSIFAL Trial.
Oncologist
; 28(1): 23-32, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239405
4.
Management of the axilla in postmenopausal patients with cN0 hormone receptor-positive/HER2-negative breast cancer treated with neoadjuvant endocrine therapy and its prognostic impact.
Breast Cancer Res Treat
; 199(3): 445-456, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37043108
5.
Self-assessment of a breast care nursing model within a Breast Unit: learning process and keys to improving breast care.
J Clin Nurs
; 32(11-12): 2722-2732, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36760012
6.
Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma.
Mod Pathol
; 35(8): 1066-1074, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35177782
7.
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study.
Lancet Oncol
; 22(2): 212-222, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33460574
8.
Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?
Breast Cancer Res Treat
; 185(3): 657-666, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33068198
9.
The effect of omitting axillary dissection and the impact of radiotherapy on patients with breast cancer sentinel node macrometastases: a cohort study following the ACOSOG Z0011 and AMAROS trials.
Breast Cancer Res Treat
; 189(1): 111-120, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34089119
10.
Duloxetine against symptomatic chemotherapy-induced peripheral neurotoxicity in cancer survivors: a real world, open-label experience.
Anticancer Drugs
; 32(1): 88-94, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332891
11.
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 21(1): 33-43, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838010
12.
A Phase II Prospective, Randomized, Double-Blind, Placebo-Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting.
Oncologist
; 25(12): e1846-1854, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32459035
13.
A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma.
Oncologist
; 24(4): 521-528, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30266892
14.
Contrast-enhancement in supratentorial low-grade gliomas: a classic prognostic factor in the molecular age.
J Neurooncol
; 143(3): 515-523, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31054099
15.
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2- advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial.
Breast Cancer Res Treat
; 169(3): 469-479, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29404806
16.
Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.
J Neurooncol
; 136(2): 363-371, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29177594
17.
Phase II trial of irinotecan and metronomic temozolomide in patients with recurrent glioblastoma.
Anticancer Drugs
; 27(2): 133-7, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26574999
18.
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.
J Neurooncol
; 127(3): 569-79, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26847813
19.
Serum micronutrients and prealbumin during development and recovery of chemotherapy-induced peripheral neuropathy.
J Peripher Nerv Syst
; 21(3): 134-41, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27282616
20.
Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study.
Breast Cancer Res Treat
; 151(3): 597-606, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25981896